Akebia Therapeutics
AKBA
#9606
Rank
ยฃ81.82 M
Marketcap
ยฃ0.29
Share price
-8.71%
Change (1 day)
-75.75%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2026 (TTM): -ยฃ32.45 Million

According to Akebia Therapeutics's latest financial reports the company's current earnings are ยฃ0.19 Billion. In 2025 the company made an earning of -ยฃ2.85 Million, an increase over its 2024 earnings that were of -ยฃ53.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ32.45 Million1040.6%
2025 -ยฃ2.85 Million-94.64%
2024 -ยฃ53.06 Million33.68%
2023 -ยฃ39.7 Million-45.12%
2022 -ยฃ72.33 Million-66.55%
2021 -ยฃ0.22 Billion-26.24%
2020 -ยฃ0.3 Billion33.94%
2019 -ยฃ0.22 Billion66.52%
2018 -ยฃ0.14 Billion123.53%
2017 -ยฃ58.8 Million-43.34%
2016 -ยฃ0.11 Billion123.58%
2015 -ยฃ46.42 Million63.95%
2014 -ยฃ28.31 Million181.24%
2013 -ยฃ10.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.31 B-43,455.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ9.66 B-29,379.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
ยฃ8.44 B-25,695.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-ยฃ0.12 Billion 254.59%๐Ÿ‡บ๐Ÿ‡ธ USA